TP53 and cancer: On the other hand, deregulation of Orai by siRNA inhibition in cancer cell lines promotes deregulation of proteins involved in the cell cycle such as cyclin-D1 and cyclin-E, as well as overexpression of p53 and p21, together with an increase in [Ca2+]i, which collectively favor apoptosis (Faouzi et al., 2011).